Ali Bourgi

Inserm, Université de Tours

Papers

2

Total Citations

42

H-Index

2

About

Ali Bourgi is a urologic surgeon and researcher whose work focuses on advancing minimally invasive treatments for renal tumors, particularly through robot-assisted partial nephrectomy (RAPN) and percutaneous cryoablation (PCA). His major contributions include comparing the oncological and perioperative outcomes of these two techniques for T1 renal masses, demonstrating that both approaches can achieve effective local control when matched for radiological stage and renal score. This work, published in 2018, has accumulated 29 citations, reflecting its influence on clinical decision-making for nephron-sparing surgery. Bourgi has also systematically evaluated surgical approaches, comparing transperitoneal versus retroperitoneal robot-assisted partial nephrectomy, providing evidence to guide operative technique selection. His research is notable for its focus on optimizing patient outcomes through careful matching and systematic review, helping to clarify the trade-offs between surgical and ablative therapies. With a growing citation record and a focus on high-impact urologic oncology, Bourgi’s work is shaping how clinicians balance oncologic efficacy with perioperative safety in renal cancer management.

Research Focus

Key Achievements

2
H-Index
2
Papers
42
Total Citations
21
Avg Citations/Paper
🏆 Most Cited Paper
Peri‐operative and local control outcomes of robot‐assisted partial nephrectomy vs percutaneous cryoablation for renal masses: comparison after matching on radiological stage and renal score
29 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: Inserm, Université de Tours

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago